Off-Label Practices Plague Circulatory System Device Randomized Trials

Off-label use of biliary stents is hindering superficial femoral artery (SFA) device development, CDRH Division of Cardiovascular Devices Director Bram Zuckerman told participants at CRT 2004 in Washington, D.C

More from Archive

More from Medtech Insight